Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.875 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD5124 |
Phase 1 |
0.8322 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8134 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8112 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8052 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8026 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD920 |
Approved |
0.7895 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7881 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7877 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7852 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7847 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7843 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7834 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7826 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7823 |
Intermediate Similarity |
NPD1243 |
Approved |
0.78 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD3266 |
Approved |
0.777 |
Intermediate Similarity |
NPD3267 |
Approved |
0.777 |
Intermediate Similarity |
NPD3750 |
Approved |
0.777 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7756 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7674 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD919 |
Approved |
0.7652 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7643 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7639 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7622 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7586 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7571 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7568 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7519 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4749 |
Approved |
0.75 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.745 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7431 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7425 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD37 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7312 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD4965 |
Approved |
0.731 |
Intermediate Similarity |
NPD7095 |
Approved |
0.731 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7296 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7267 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7266 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7985 |
Registered |
0.725 |
Intermediate Similarity |
NPD5353 |
Approved |
0.725 |
Intermediate Similarity |
NPD2415 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7226 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7218 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7214 |
Intermediate Similarity |
NPD17 |
Approved |
0.7212 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7183 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7162 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7122 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD7644 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7114 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7108 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7097 |
Intermediate Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD1512 |
Approved |
0.707 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7039
|
Intermediate Similarity |
NPD4477 |
Approved |